NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/09/2024
Back to search
Official data from USPTO
SILENT DESIGN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SILENT DESIGN
ST13
US500000088232438Class
1, 5
Filing
88232438
Registration
7265521
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
63
Latest update
01/09/2024
Trademark type
Word
Nice classes
1, 5
Filing date
12/17/2018
Registration date
01/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/09/2024
Last transaction
01/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Kobe, Hyogo, JP
Examiner
ANKRAH, NAAKWAMA S
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. C. (pessoa física)
Representatives
Jennifer Theis CROWELL & MORING
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical reagents other than for medical or veterinary purposes; chemical preparations for scientific purposesincluding non-therapeutic ingredients used in pharmaceutical manufacture; diagnostic chemicals for scientific or research usereagents used in laboratory for scientific purposes; diagnostic reagents and diagnostic preparationsother than for medical or veterinary purposes; reagents for hematology analysis for scientific or research use; reagents for reticulocyte analysis for scientific or research use; reagents for blood coagulation analysis for scientific or research use; reagents for urinalysis for scientific or research use; reagents for immunoassay for scientific or research use; reagents for clinical chemistry testing for scientific or research use; reagents for gene test for scientific or research use; lysing solutionsreagents used for hemolysing whole blood sample for scientific purposes; chemical reagent stains for industrial use; chemicalssheath solutions for industrial use; reference control chemicals for industrial use; chemical reference materials for industrial use; chemical agentsquality control standard solutions and quality control chemicals for industrial use for testing and calibrating medical apparatus and reagents; hematology control chemicals for testing and calibrating medical apparatus and reagents; hematology control chemicals for industrial use; standard serum for scientific or research use; control serum for scientific or research use; biochemical standard serum for scientific or research use; biochemical control serum for scientific or research use; chemical agentsquality control standard solutions and quality control chemicals for testing and calibrating medical apparatus and reagents; stains for medical or clinical laboratory use; stains for hematology analysis for medical or clinical laboratory use; stains for reticulocyte analysis for medical or clinical laboratory use; stains for urinalysis for medical or clinical laboratory use; stains for immunoassay for medical or clinical laboratory use
Class 5
Sanitary preparations for medical use; diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; testing reagents for clinical medical or medical diagnostic use; reagents for hematology analysis for clinical medical or medical diagnostic use; reagents for blood analysis for clinical medical or medical diagnostic use; reagents for white blood cell analysis for clinical medical or medical diagnostic use; reagents for immature cell analysis for clinical medical or medical diagnostic use; reagents for hemoglobin analysis for clinical medical or medical diagnostic use; reagents for reticulocyte analysis for clinical medical or medical diagnostic use; reagents for erythrocyte analysis for clinical medical or medical diagnostic use; reagents for nucleated red cell analysis for clinical medical or medical diagnostic use; reagents for blood coagulation analysis for medical or veterinary purposes; reagents for urinalysis for medical or veterinary purposes; reagents for urinary sediment analysis for medical or veterinary purposes; reagents for immunoassay for medical or veterinary purposes; reagents for bacteria analysis for medical or veterinary purposes; reagents for clinical chemistry testing for medical or veterinary purposes; reagents for genetic test for medical or veterinary purposes; reagents for protein test for medical or veterinary purposes; reagents for cancer recurrence prediction test for medical or veterinary purposes; reagents for anticancer drug sensitivity prediction test for medical or veterinary purposes; diluents for clinical medical or medical diagnostic use; diluents for hematology analysis for medical or veterinary purposes; diluents for reticulocyte analysis for medical or veterinary purposes; diluents for urinalysis for medical or veterinary purposes; diluents for immunoassay for medical or veterinary purposes; medical diagnostic reagents and solutionslysing solutions and reagents and hemolytic lysing solutions and reagents for hemolysing whole blood sample for medical or veterinary purposes; medical diagnostic reagents and solutionssheath solutions to be used in detecting analyte using flow cytometry for medical use; hematology control reagents for medical use; reference control reagents for medical use
Publications
History of USPTO decisions and trademark events.
63 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/09/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
12/05/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
10/05/2023
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
10/05/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/18/2023
EX5G
SOU EXTENSION 5 GRANTED
04/17/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2023
EXT5
SOU EXTENSION 5 FILED
04/12/2023
EEXT
SOU TEAS EXTENSION RECEIVED
04/12/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/09/2022
EX4G
SOU EXTENSION 4 GRANTED
11/07/2022
EXT4
SOU EXTENSION 4 FILED
11/07/2022
EEXT
SOU TEAS EXTENSION RECEIVED
11/07/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2022
EX3G
SOU EXTENSION 3 GRANTED
05/02/2022
EXT3
SOU EXTENSION 3 FILED
05/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/12/2021
EX2G
SOU EXTENSION 2 GRANTED
11/10/2021
EXT2
SOU EXTENSION 2 FILED
11/10/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/10/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2021
EX1G
SOU EXTENSION 1 GRANTED
05/07/2021
EXT1
SOU EXTENSION 1 FILED
05/07/2021
EEXT
SOU TEAS EXTENSION RECEIVED
05/07/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
09/10/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/01/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/01/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/01/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/31/2020
GNRT
NON-FINAL ACTION E-MAILED
03/31/2020
CNRT
NON-FINAL ACTION WRITTEN
03/31/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/04/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/06/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
11/21/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
11/21/2019
CNSI
SUSPENSION INQUIRY WRITTEN
11/21/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/06/2019
ALIE
ASSIGNED TO LIE
10/29/2019
ALIE
ASSIGNED TO LIE
10/15/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/26/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/26/2019
CNSL
SUSPENSION LETTER WRITTEN
03/26/2019
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/26/2019
ISSR
WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST
03/26/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2019
PUBO
PUBLISHED FOR OPPOSITION
03/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
02/20/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2019
DOCK
ASSIGNED TO EXAMINER
01/31/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2019
NWAP
NEW APPLICATION ENTERED
12/20/2018
Continuous trademark protection
Get notified about every new filing that threatens SILENT DESIGN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.